Data spanning the past 90 days through February 07, 2026 reveals that Corvus Pharmaceuticals's three principal insider shareholders consist of Director Peter A. Thompson (7.38Mn shares), Director Advisors Llc Orbimed (7.17Mn shares), President And Ceo Richard A Md Miller (2.32Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Peter A. Thompson | 7,375,006 | 30 Jan, 2026 | |
| Advisors Llc Orbimed | 7,165,006 | 01 Jul, 2025 | |
| Richard A Md Miller | President And Ceo | 2,324,810 | 09 May, 2025 |
| William Benton Jones | Nan | 173,130 | 06 Jun, 2025 |
| Leiv Lea | Chief Financial Officer | 133,238 | 15 Dec, 2022 |
| Capital, Llc Ecor1 | 81,077 | 01 Oct, 2021 | |
| Linda Grais | 10,000 | 16 May, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $1.64 | 195,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.00 | 90,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $12.50 | 60,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 30,000 | $15.00 | 30,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $0.99 | 150,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.12 | 210,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $3.27 | 105,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $3.61 | 75,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $9.70 | 45,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.49 | 180,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $0.96 | 165,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.60 | 135,000 | D | M |
| 28 Jan, 2026 | Peter A. Thompson | Common Stock | A | 15,000 | $2.74 | 120,000 | D | M |
| 27 Jun, 2025 | Advisors Llc Orbimed | - | - | 7,165,006 | I | |||
| 27 Jun, 2025 | Advisors Llc Orbimed | Common Stock | A | 1,397,684 | $3.50 | 8,341,338 | I | X |
| 27 Jun, 2025 | Advisors Llc Orbimed | Common Stock | D | 1,176,332 | $4.16 | 7,165,006 | I | S |
| 27 Jun, 2025 | Advisors Llc Orbimed | - | - | 8,341,338 | I | |||
| 27 Jun, 2025 | Peter A. Thompson | Common Stock | D | 1,176,332 | $4.16 | 7,165,006 | I | S |
| 27 Jun, 2025 | Peter A. Thompson | Common Stock | A | 1,397,684 | $3.50 | 8,341,338 | I | X |
| 04 Jun, 2025 | William Benton Jones | Common Stock | A | 19,357 | $3.50 | 173,130 | D | M |